Equities

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,820.00
  • Today's Change-36.00 / -1.94%
  • Shares traded536.27k
  • 1 Year change+0.86%
  • Beta0.3859
Data delayed at least 20 minutes, as of Nov 05 2024 16:48 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue2,8752,5172,553
OPERATING EXPENSES
Cost of revenue total1,4681,2521,252
Selling, general and admin. expenses, total544509488
Depreciation/amortization889273
Unusual expense(income)260200(39)
Other operating expenses, total4.001138
Total operating expense2,5132,2081,955
Operating income362309598
Other, net(14)(11)(13)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes281233544
Provision for income taxes8942124
Net income after taxes192191420
Minority interest(2)(3)1.00
Net income before extra. Items190188421
Total extraordinary items------
Net income190188421
Inc.avail. to common excl. extra. Items190188421
Inc.avail. to common incl. extra. Items190188421
EPS RECONCILIATION
Basic/primary weighted average shares221224233
Basic/primary eps excl. extra items0.860.841.81
Basic/primary eps incl. extra items0.860.841.81
Dilution adjustment------
Diluted weighted average shares222225233
Diluted eps excl. extra items0.850.841.81
Diluted eps incl. extra items0.850.841.81
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.730.560.55
Gross dividend - common stock159124125
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental735943
SUPPLEMENTAL INCOME
Depreciation, supplemental959083
Total special items260200(39)
NORMALISED INCOME
Normalized income before taxes541433505
Effect of special items on income taxes(42)(69)(5)
Income tax excluding impact of special items47(27)119
Normalized income after tax494460386
Normalized income avail. to common492457387
Basic normalized EPS2.232.041.66
Diluted normalized EPS2.212.031.66
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.